Part 6

ISHD Hemodialysis University™
Hyderabad, India.  March 1st & 2nd 2014
     HDCN free zone registration is required.
Infections in the Hemodialysis Unit
Victor Gura, MD
Questions and Answers
Emerging technologies in Hemodialysis
Victor Gura, MD
Questions and Answers
Hazards of Benzyl alcohol as preservative in Heparin
K. S. Nayak, MD
Questions and Answers

K. S. Nayak, MD
Head - Department of Renal Sciences
Dialysis Centres & Renal Transplant Programme
Deccan Hospital
Hyderabad, India

Victor Gura, MD
Associate Clinical Professor of Medicine
Cedars Sinai Medical Center
The David Geffen School of Medicine
University of California, LA
This educational activity is an audio recording with accompanying slides of a live presentation held on March 1st and 2nd, 2014, in Hyderabad, India. Continuing medical education credit is not available for this on-line archive.

The Web archiving and presentation of this symposium was made possible by an unrestricted educational grant from Baxter Healthcare to the International Society for Hemodialysis.

To view this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from is useful but not necessary to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the slide handouts.

Program Overview:

Target Audience:
This program is intended for practicing Nephrologists, nephrology fellows, dialysis technologists, interventional nephrologists, vascular access surgeons, and health professionals involved in dialysis programs.
Disclosure Policy:
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.

Off-label/lnvestigational Use:
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.

The policy statements of HDCN are listed on this page.